SMTL ID : 6jvq.2 (1 other biounit)

Crystal structure of human MTH1 in complex with compound MI1025

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x CJF: N4-cyclopropyl-6-morpholin-4-yl-pyrimidine-2,4-diamine(Non-covalent)

CJF.1: 13 residues within 4Å: Chain A: Y.7, T.8, L.9, F.27, N.33, F.72, F.74, M.81, W.117, D.119, D.120, W.123, F.139 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.27, A:F.72, A:F.74, A:F.74, A:W.117, A:F.139 Hydrogen bonds: A:N.33, A:N.33, A:D.119 Salt bridges: A:D.119, A:D.120 pi-Stacking: A:W.117

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Peng, C. et al., Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity. Bioorg.Chem. (2021)

Release Date

2020-10-28

Peptides

7,8-dihydro-8-oxoguanine triphosphatase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

7,8-dihydro-8-oxoguanine triphosphatase

Related Entries With Identical Sequence